Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2017 (2017), Article ID 2790741, 4 pages
https://doi.org/10.1155/2017/2790741
Case Report

Isolated Liver Metastasis in Hürthle Cell Thyroid Cancer Treated with Microwave Ablation

1Endocrinology, Diabetes and Metabolism, The Ohio State University Wexner Medical Center, 5th Floor McCampbell Hall, 1581 Dodd Drive, Columbus, OH 43210, USA
2Surgical Oncology, The Ohio State University Wexner Medical Center, N-924 Doan Hall, 410 W. 10th Avenue, Columbus, OH 43210, USA

Correspondence should be addressed to Fadi Nabhan

Received 6 November 2016; Accepted 25 December 2016; Published 9 January 2017

Academic Editor: Osamu Isozaki

Copyright © 2017 Konstantinos Segkos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Besic, A. Schwarzbartl-Pevec, B. Vidergar-Kralj, T. Crnic, B. Gazic, and M. Marolt Music, “Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience,” BMC Cancer, vol. 16, no. 1, article 162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Kushchayeva, Q.-Y. Duh, E. Kebebew, and O. H. Clark, “Prognostic indications for Hürthle cell cancer,” World Journal of Surgery, vol. 28, no. 12, pp. 1266–1270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Bhattacharyya, “Survival and prognosis in Hürthle cell carcinoma of the thyroid gland,” Archives of Otolaryngology—Head and Neck Surgery, vol. 129, no. 2, pp. 207–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Ganly, J. R. Filho, S. Eng et al., “Genomic dissection of hurthle cell carcinoma reveals a unique class of thyroid malignancy,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 5, pp. E962–E972, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Nagar, B. Aschebrook-Kilfoy, E. L. Kaplan, P. Angelos, and R. H. Grogan, “Hurthle cell carcinoma: an update on survival over the last 35 years,” Surgery, vol. 154, no. 6, pp. 1263–1271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H.-J. Song, Y.-L. Xue, Y.-H. Xu, Z.-L. Qiu, and Q.-Y. Luo, “Rare metastases of differentiated thyroid carcinoma: pictorial review,” Endocrine-Related Cancer, vol. 18, no. 5, pp. R165–R174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Farina, F. Monari, G. Tallini et al., “Unusual thyroid carcinoma metastases: a case series and literature review,” Endocrine Pathology, vol. 27, no. 1, pp. 55–64, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Djenic, D. Duick, J. O. Newell, and M. J. Demeure, “Solitary liver metastasis from follicular variant papillary thyroid carcinoma: a case report and literature review,” International Journal of Surgery Case Reports, vol. 6, pp. 146–149, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kouso, T. Ikegami, T. Ezaki et al., “Liver metastasis from thyroid carcinoma 32 years after resection of the primary tumor: report of a case,” Surgery Today, vol. 35, no. 6, pp. 480–482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kondo, R. Katoh, K. Omata, T. Oyama, A. Yagawa, and A. Kawaoi, “Incidentally detected liver metastasis of well-differentiated follicular carcinoma of the thyroid, mimicking ectopic thyroid,” Pathology International, vol. 50, no. 6, pp. 509–513, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. M. W. Graves, B. Zukerberg, K. Walace, D. Duncan, and A. Scheff, “Isolated liver metastases from follicular thyroid cancer,” Clinical Nuclear Medicine, vol. 21, no. 2, pp. 147–148, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ohwada, Y. lino, Y. Kawashima et al., “Solitary metastasis from papillary thyroid carcinoma in cirrhotic liver with hepatocellular carcinoma,” Japanese Journal of Clinical Oncology, vol. 23, no. 5, pp. 309–312, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Studer, P. Veraguth, and F. Wyss, “Thyrotoxicosis due to a solitary hepatic metastasis of thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 21, pp. 1334–1338, 1961. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Salvatori, G. Perotti, V. Rufini et al., “Solitary liver metastasis from Hürthle cell thyroid cancer: a case report and review of the literature,” Journal of Endocrinological Investigation, vol. 27, no. 1, pp. 52–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Besic, B. Vidergar-Kralj, S. Frkovic-Grazio, T. Movrin-Stanovnik, and M. Auersperg, “The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid,” Thyroid, vol. 13, no. 6, pp. 577–584, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Lopez-Penabad, A. C. Chiu, A. O. Hoff et al., “Prognostic factors in patients with Hürthle cell neoplasms of the thyroid,” Cancer, vol. 97, no. 5, pp. 1186–1194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Chindris, J. D. Casler, V. J. Bernet et al., “Clinical and molecular features of Hürthle cell carcinoma of the thyroid,” Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 1, pp. 55–62, 2015. View at Publisher · View at Google Scholar
  18. G. Treglia, S. Annunziata, B. Muoio, M. Salvatori, L. Ceriani, and L. Giovanella, “The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview,” International Journal of Endocrinology, vol. 2013, Article ID 856189, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Wong and A. Cooper, “Local ablation for solid tumor liver metastases: techniques and treatment efficacy,” Cancer Control, vol. 23, no. 1, pp. 30–35, 2016. View at Google Scholar · View at Scopus
  20. J. Hof, M. W. J. L. A. E. Wertenbroek, P. M. J. G. Peeters, J. Widder, E. Sieders, and K. P. De Jong, “Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases,” British Journal of Surgery, vol. 103, no. 8, pp. 1055–1062, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Shibata, T. Niinobu, N. Ogata, and M. Takami, “Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma,” Cancer, vol. 89, no. 2, pp. 276–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Leung, D. Kuk, M. I. D'Angelica et al., “Long-term outcomes following microwave ablation for liver malignancies,” British Journal of Surgery, vol. 102, no. 1, pp. 85–91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Mohan, P. Nicholson, D. C. Winter et al., “Radiofrequency ablation for neuroendocrine liver metastases: a systematic review,” Journal of Vascular and Interventional Radiology, vol. 26, no. 7, pp. 935–942.e1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. W. J. L. A. E. Wertenbroek, T. P. Links, T. R. Prins, J. T. M. Plukker, E. J. Van Der Jagt, and K. P. De Jong, “Radiofrequency ablation of hepatic metastases from thyroid carcinoma,” Thyroid, vol. 18, no. 10, pp. 1105–1110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M.-H. Massicotte, M. Brassard, M. Claude-Desroches et al., “Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network,” European Journal of Endocrinology, vol. 170, no. 4, pp. 575–582, 2014. View at Publisher · View at Google Scholar · View at Scopus